Search Results

You are looking at 381 - 390 of 1,416 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Christina Rybak and Michael J. Hall

Colorectal cancer (CRC) risk assessment involves evaluation of an individual's personal and family history for characteristics of an inherited susceptibility to develop CRC. These characteristics include early age at diagnosis, multiple primary

Full access

Elizabeth R. Plimack and Gary R. Hudes

particular patient can be daunting for clinicians. This article describes how treatment choices can be guided by the disease setting, histology, patient characteristics and comorbidities, and patient preference. Adjuvant or Neoadjuvant Therapy for Localized

Full access

Jonas A. de Souza, Mark J. Ratain, and A. Mark Fendrick

, and patient characteristics influence treatment choices . Oncologist 2010 ; 15 : 566 - 576 . 32 Newcomer LN . Trying something new: episode payments for cancer therapy . J Oncol Pract 2011 ; 7 ( Suppl 3 ): S60 - 61 . 33

Full access

Hillary Johnson-Jahangir, William Sherman, and Désirée Ratner

tumorigenesis. 15 – 17 No correlation exists between COL1A1 breakpoints and any particular clinical or histopathologic characteristics. 18 , 19 Imatinib in the Treatment of DFSP Understanding the molecular pathogenesis of DFSP serves as a basis for

Full access

Kah Poh Loh, Ankit Kansagra, Meng-Shiou Shieh, Penelope Pekow, Peter Lindenauer, Mihaela Stefan, and Tara Lagu

Database (SID), and the American Hospital Association (AHA) Annual Survey Database. The California SID includes 100% of state's inpatient discharge records from the hospitals. Demographic characteristics, payer information, principal diagnoses, cost

Full access

Caitlin A. Hester, Nicole E. Rich, Amit G. Singal, and Adam C. Yopp

). Tumor characteristics of interest included the number of lesions, maximum tumor diameter, lymph node involvement, portal vein invasion, presence of extrahepatic metastases, and tumor stage at diagnosis. The Barcelona Clinic Liver Cancer (BCLC) system was

Full access

Rita A. Mukhtar, Jasmine M. Wong, and Laura J. Esserman

Cancer Inst 2010 ; 102 : 627 – 637 . 30. Barnes NL Dimopoulos N Williams KE . The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast . Eur J Surg

Full access

Margaret von Mehren, R. Lor Randall, Robert S. Benjamin, Sarah Boles, Marilyn M. Bui, Ernest U. Conrad III, Kristen N. Ganjoo, Suzanne George, Ricardo J. Gonzalez, Martin J. Heslin, John M. Kane III, Henry Koon, Joel Mayerson, Martin McCarter, Sean V. McGarry, Christian Meyer, Richard J. O'Donnell, Alberto S. Pappo, I. Benjamin Paz, Ivy A. Petersen, John D. Pfeifer, Richard F. Riedel, Scott Schuetze, Karen D. Schupak, Herbert S. Schwartz, William D. Tap, Jeffrey D. Wayne, Mary Anne Bergman, and Jillian Scavone

Diagnosis of STS Molecular genetic testing has emerged as a particularly useful ancillary technique, because many subtypes of STS are associated with characteristic genetic aberrations, including single base-pair substitutions, deletions, amplifications

Full access

Jonathan Potack and Steven H. Itzkowitz

performance characteristics to various populations. 5 Although gFOBT is fairly standardized, many FIT kits are marketed, each with its own unique test characteristics. Significant variability exists between antigen target stability and stool sampling

Full access

Jeff Dang, Sang Chau, Jessy Delaisla, Divya Prakash, and Andrew Hertler

how long metastatic NSCLC patients were on first-line treatments and what characteristics potentially contribute to the duration of therapy prior to progression. Methods: All patients with a diagnosis of metastatic NSCLC that received first line